TLSI NASDAQ
Credit Risk of going bust: higher than 75% of companies Debt: 13.4% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.09 (down 98%), TriSalus Life Sciences, Inc. would be worth roughly what it owes.
Total debt $34.4M against a stock market value of $222.9M.
Distance to default 3.00 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $16.5M (short-term plus half of long-term), stock volatility 85.4%; Altman Z -4.72. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Westminster, CO 80031
US
TriSalus Life Sciences, Inc. is an immunotherapy firm dedicated to the research, development, and market introduction of treatments that leverage the body's immune system, primarily targeting liver and pancreatic cancers. The company's product portfolio includes the TriNav Infusion System, designed for hepatic arterial infusion to treat liver tumors, and the Pancreatic Retrograde Venous Infusion System, which addresses pancreatic tumors. Additionally, TriSalus is advancing SD-101, an investigational immunotherapeutic that incorporates pressure-enabled drug delivery technology. This experimental therapy is currently being explored for its application in hepatocellular carcinoma, intrahepatic cholangiocarcinoma, uveal melanoma with liver metastases, pancreatic ductal adenocarcinoma with liver metastases, colorectal cancer with liver metastases, and primary pancreatic cancers. The company's operations are headquartered in Westminster, Colorado.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Cox Bryan F. | S-Sale | 296 | $4.39 | 2026-10-05 |
| Marshak Richard | S-Sale | 325 | $4.39 | 2026-10-05 |
| Stevens Jennifer | S-Sale | 316 | $4.39 | 2026-10-05 |
| Szela Mary T | F-InKind | 2,693 | $4.38 | 2026-10-05 |
| Patience David | F-InKind | 14,650 | $4.46 | 2026-07-01 |